Cargando…

Association between Plasma Metabolic Profiles of the Antidepressant Escitalopram and Clinical Response in Subjects with Depression

Liquid chromatography/electrospray ionization-mass spectrometry revealed plasma metabolic profiles for the antidepressant drug escitalopram (ECTP) and associated clinical responses in subjects with major depressive disorder (MDD). Metabolic profiles contribute to variations in responses to drug trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandu, Raju, Lee, Hyun Jeong, Lee, Hyeong Min, Ha, Tae Hyon, Lee, Heon-Jeong, Kim, Se Joo, Ha, Kyooseob, Kim, Kwang Pyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mass Spectrometry Society of Japan 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338262/ https://www.ncbi.nlm.nih.gov/pubmed/37456152 http://dx.doi.org/10.5702/massspectrometry.A0123

Ejemplares similares

PS207. Integrated systems analysis of serum proteome profiles of individual drug responses in MDD patients
por: Lee, Hyun Jeong, et al.
Publicado: (2016)

PS70. Treatment outcome of the acute depressive episode in patients with bipolar disorders with suicide attempts
por: Ryu, Jeong Eun, et al.
Publicado: (2016)

PS66. The protective effects of hypomanic symptoms in a major depressive episode on suicide attempt in bipolar disorder
por: Lee, Jongha, et al.
Publicado: (2016)

Polarity of the First Episode and Time to Diagnosis of Bipolar I Disorder
por: Cha, Boseok, et al.
Publicado: (2009)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016)

Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder
por: Kim, Jae-Won, et al.
Publicado: (2013)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Lee, Hyunju, et al.
Publicado: (2021)

Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology
por: Bandu, Raju, et al.
Publicado: (2019)

Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder
por: Sun, Zuoli, et al.
Publicado: (2023)

Comparative lipidomics of 5-Fluorouracil–sensitive and –resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1)
por: Jung, Jae Hun, et al.
Publicado: (2020)

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression
por: Han, Kyu-Man, et al.
Publicado: (2013)

Is Advancing Circadian Rhythm the Mechanism of Antidepressants?
por: Lee, Heon-Jeong
Publicado: (2019)

Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression
por: García-Durán, Laura, et al.
Publicado: (2021)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
por: Yin, Juntao, et al.
Publicado: (2023)

Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
por: Lee, Jeong-Ok, et al.
Publicado: (2018)

Management of Bipolar Depression
por: Chang, Jae Seung, et al.
Publicado: (2011)

An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks
por: Kim, Eun Young, et al.
Publicado: (2020)

PT559. The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects
por: An, Hoyoung, et al.
Publicado: (2016)

The genome‐wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response
por: Powell, Timothy R., et al.
Publicado: (2017)

Comparison of serum protein profiles between major depressive disorder and bipolar disorder
por: Rhee, Sang Jin, et al.
Publicado: (2020)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Differential effects of antidepressants escitalopram versus lithium on Gs alpha membrane relocalization
por: Donati, Robert J, et al.
Publicado: (2015)

Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study
por: Bandu, Raju, et al.
Publicado: (2015)

Similarities of Aspects of Biological Rhythms between Major Depression and Bipolar II Disorder Compared to Bipolar I Disorder: A Finding from the Early-Onset Mood Disorder Cohort
por: Kim, Su Cheol, et al.
Publicado: (2019)

Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effects in a Mouse Model of Depression
por: Kim, Shinheun, et al.
Publicado: (2016)

Latent class analysis of psychotic-affective disorders with data-driven plasma proteomics
por: Rhee, Sang Jin, et al.
Publicado: (2023)

Depression in Acromegaly Treated with Escitalopram and Cognitive Therapy
por: De Sousa, Avinash
Publicado: (2009)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022)

Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
por: Lee, Bun-Hee, et al.
Publicado: (2014)

Association of stress, depression, and suicidal ideation with subjective oral health status and oral functions in Korean adults aged 35 years or more
por: Kim, Young Sun, et al.
Publicado: (2017)

Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
por: Woo, Young Sup, et al.
Publicado: (2017)

Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial
por: Paulus, Martin P., et al.
Publicado: (2021)

Prediction of Antidepressant Treatment Outcome Using Event-Related Potential in Patients with Major Depressive Disorder
por: Lee, Hyun Seo, et al.
Publicado: (2020)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018)

Sexual functioning in females with depression in remission receiving escitalopram
por: Roy, Pritha, et al.
Publicado: (2019)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
por: Gammoh, Omar, et al.
Publicado: (2023)

Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression
por: Joodaki, Mehran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6flbknbcl0oo4fulureesco0dh